-
PROVIDERS
Learn more
Join Tempus at the 2026 ASCO® Annual Meeting!
-
LIFE SCIENCES
Read case study
Learn now Tempus Next Pathways unlocked critical insights into the aNSCLC patient journey with Bristol Myers Squibb (BMS)
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Resources
Webinars
-
05/05/2026From recurrence monitoring to treatment response: MRD data insights across the cancer care continuum
This session will explore how minimal residual disease (MRD) data provides critical insights across the cancer care continuum.Speakers: Peter Prieto, MD, Senior Vice President, Medical Affairs
Watch replay
Luis Raez, MD, Medical Director Memorial Cancer Institute
Alan Tan, MD, Vice President, MRD Research & Clinical Strategy -
04/02/2026Unlocking foundation models: Our experience from proof of concept to deployment at scale
An executive discussion on leveraging multi-modal foundation models to accelerate your drug development journeySpeakers: Razik Yousfi, SVP, AI Products
Watch replay
Arpita Saha, VP, Applied AI and Research
Siqi Liu, VP, Machine Learning -
03/24/2026Translating data into an actionable R&D strategy
Hear from industry leaders about how a data-driven understanding of disease biology can inform critical decisions and accelerate therapeutic development.Speakers: Phil Perez
Watch replay
Senior Vice President, Commercial Life Sciences, Tempus
Martin Bontrager, PhD
Vice President, Translational Research, Tempus
Dave Lennon, PhD
President & CEO, Whitehawk Therapeutics -
01/29/2026Ask a scientist: How to leverage novel datasets to answer complex research questions
Learn how Tempus helps researchers use specialized data to answer complex research questions. This discussion explores how analysis-ready datasets can accelerate discovery and power new hypotheses in immuno-oncology.Speakers:
Watch replay -
12/11/2025Driving enterprise value with RWD
Hear from biotech CEOs and VC leaders as they discuss how real-world data can inform strategic decision-making in biotech companies.Speakers: Andy Moye, PhD
Watch replay
SVP & GM of Data Products, Tempus
Matthew Price, Co-Founder & COO
Director, Promontory
Nick Glover, PhD, CEO
MycRx
Brad Hirsch, MD, Co-Founder
Highlander Health -
12/04/2025Pioneering decentralized oncology trials: Success at the nation’s largest community practices
Hear directly from industry leaders and pioneering site partners as they share insights on expanding their research footprint and improving financial sustainability for their institutions.Speakers: Noelle Gaskill, MBA, ACRP-CP
Watch replay
VP, General Manager, TIME Network, Tempus
Jessica Bivins, VP
Clinical Research, OneOncology
Scott Paulson, MD
Director of Clinical Research, Texas Oncology
Sameek Roychowdhury, MD, PhD
Professor, The Ohio State University
-
11/11/2025A new era of biopharma R&D: The TechBio revolution—realities and the next frontier
Join Tempus and Recursion leaders to explore their strategic TechBio partnership. Learn how they use AI and supercomputing with petabytes of data to accelerate drug discovery and development. See the impact on biopharma R&D's future.Speakers: Sid Jain
Watch replay
Senior Vice President of Clinical Development & Data Science, Recursion
Hayley Donnella, PhD
Vice President of Frontier Research, Recursion
Shane Woods, PhD
Chief Strategy Officer, Tempus -
11/06/2025Beyond imaging: Leveraging molecular tools to detect MRD for personalized cancer care
This webinar explores the clinical value of MRD testing and IO treatment response monitoring in oncology, using real-world cases to illustrate its application in patient management.Speakers:
Watch replay -
10/21/2025How to reduce your documentation burden with AI
Discover how an AI-powered clinical notetaker can reduce documentation stress and add time back into your day.Speakers:
Watch replay -
10/01/2025Uncovering the uncommon in rare cancers: Diagnostic innovation driving change
Experts highlight how integrating AI and multimodal data can uncover deeper insights in rare cancers, enhance trial opportunities, and inform treatment strategies.Speakers: Ezra Cohen,
Watch replay
Chief Medical Officer of Oncology, Tempus,
Razelle Kurzrock, MD, FACP
Center Associate Director, Professor of Medical College of Wisconsin